.N. et al., J. Biotech., 28(2-3), 277-289
(1993).
6. Rao, M.D. et al., World J. Microbiol. Biotech., 18 ,
547-550 (2002).
7. Machius, M. et al., J. Mol. Biol., 246(4), 545-559
(1995).
8.
.N. et al., J. Biotech., 28(2-3), 277-289
(1993).
6. Rao, M.D. et al., World J. Microbiol. Biotech., 18 ,
547-550 (2002).
7. Machius, M. et al., J. Mol. Biol., 246(4), 545-559
(1995).
8.
., et al., J. Biotech., 28(2-3), 277-289
(1993).
6. Rao, M.D., et al., World J. Microbiol. Biotech., 18 ,
547-550 (2002).
7. Machius, M., et al., J. Mol. Biol., 246(4), 545-559
(1995).
8.
.N. et al., J. Biotech., 28(2-3), 277-289
(1993).
6. Rao, M.D. et al., World J. Microbiol. Biotech., 18 ,
547-550 (2002).
7. Machius, M. et al., J. Mol. Biol., 246(4), 545-559
(1995).
Enzymes: A Practical Approach, R.J. Beynon and J.S. Bond, Eds., IRL Press, Oxford,
England, 246, (1989).
2. Chemical Abstracts Registry data, American Chemical Society.
3. Sigma Quality Control data
marker for
agarose or acrylamide gel electrophoresis.
Ratio A260/A280: 1.8
Concentration: 246 µg/ml
Storage Buffer
10 mM Tris-HCl, pH 8.0
1 mM EDTA
Suitability Assay
pUC18 Msp I digest
Description
Recombinant human EphA1 extracellular domain/Fc
chimera consists of amino acid residues 1-547
(extracellular domain of human EphA1)1 that was fused
by means of a polypeptide linker to the Fc
Jordan, V.C., Academic, Sydney, Australia, 1981, 59.
17. Murphy, C. et al., J. Steroid Biochem. 26, 547, (1987).
18. Precigoux, G. et al., Acta Cryst. B35:3070, (1979).
19. Lau, C.K. et al., Proc. Natl
V.C., Academic, Sydney, Australia, 1981, 59 (review).
17. Murphy, C. et al., J. Steroid Biochem. 26, 547, (1987).
18. Precigoux, G. et al., Acta Cryst. B35:3070, (1979).
19. Martindale, The Extra Pharmacopoeia
Johnson, G.V., Cyclin-
dependent kinase-5 in neurodegeneration. J
Neurochem., 88(6),1313-26 (2004).
2. Hisanaga, S., and Saito, T., The regulation of
cyclin-dependent kinase 5 activity through
J.E.F. Reynolds, 30 ed., pp. 650-651 (1993).
21. Minor, A.H. and Burnett, L., N.Y. State J. Med., 53, 547 (1953).
22. Boyum, A., Scan. J. Clin. Lab. Invest., 21, Suppl. 97, 31 (1968).
23. Harris, R. and Ukaejiofo
On eosinophils, the effects of eotaxin-2 were shown to
be inhibited by an anti-CCR-3 antibody and to be cross-
desensitized by eotaxin or MCP-4 (Cat. No.
M-246), suggesting that all three CC chemokines